News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Nova Mentis Receives Controlled Substances Export Approval From The U.S. DEA For The Company’s Proprietary Psilocybin Drug NM 1001
June 7, 2022
·
2 min read
Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents
June 7, 2022
·
6 min read
BioMark Diagnostics and the Icahn School of Medicine at Mount Sinai Announce Partnership to Advance Early Lung Cancer Screening Technology
June 7, 2022
·
5 min read
Nirvana Life Sciences Announces Positive Results for Addiction Relapse Prevention from Their Latest Pre-Clinical Psychedelic Drug Study
June 2, 2022
·
7 min read
Awakn Life Sciences Initiates Follow-On Behavioral Study to Focus on Gambling Disorder
June 2, 2022
·
6 min read
FDA
Therma Bright Provides Update on FDA EUA Application Process For AcuVid(TM) COVID-19 Rapid Antigen Saliva Test
June 2, 2022
·
5 min read
Get In Touch With QBiotics to Discuss Its Positive Solid Tumor Efficacy Data and Phase II Clinical Program at Bio 2022
June 1, 2022
·
1 min read
NervGen Pharma Grants Stock Options - May 31,2022
May 31, 2022
·
1 min read
Kiora Pharmaceuticals Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
May 31, 2022
·
4 min read
Deals
PharmaDrug Announces Execution Of an Agreement to Sell Its German Cannabis Asset to Khiron
May 31, 2022
·
8 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us